Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-055774
Filing Date
2024-05-08
Accepted
2024-05-08 16:30:23
Documents
1
Period of Report
2024-01-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4930
  Complete submission text file 0000950170-24-055774.txt   6615
Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
STAAB THOMAS R II (Reporting) CIK: 0001230708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39473 | Film No.: 24926677

Mailing Address 2800 DISCOVERY DRIVE SUITE 100 ORLANDO FL 32826
Business Address 2800 DISCOVERY DRIVE SUITE 100 ORLANDO FL 32826 888-536-7271
LENSAR, Inc. (Issuer) CIK: 0001320350 (see all company filings)

EIN.: 320125724 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)